Dupixent Succeeds Where Other Biologic Drugs Failed – In COPD

Efficacy In Phase III Trial Exceeded Expectations

 
• By Jessica Merrill
key in lock
Dupixent holds a key to success in Phase III • Source: Shutterstock

More from Respiratory

More from Therapy Areas